These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4048474)

  • 1. Controversies in the treatment of Parkinson's disease.
    Hershey LA
    Ration Drug Ther; 1985 Feb; 19(2):1-4. PubMed ID: 4048474
    [No Abstract]   [Full Text] [Related]  

  • 2. Controversies in the management of Parkinson's disease.
    Calne DB; Rinne UK
    Mov Disord; 1986; 1(3):159-62. PubMed ID: 3143065
    [No Abstract]   [Full Text] [Related]  

  • 3. Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
    Godwin-Austen RB
    Adv Biochem Psychopharmacol; 1980; 23():261-5. PubMed ID: 7395616
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bromocriptine versus levodopa in the early treatment of Parkinson's disease. 1st results after 2 years].
    Montastruc JL; Rascol O; Rascol A
    Therapie; 1988; 43(6):461-3. PubMed ID: 3227512
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Duvoisin RC; Mendoza MM; Yahr MD
    Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on the treatment of Parkinson's disease.
    Wirz D
    Conn Med; 1985 Oct; 49(10):633-7. PubMed ID: 3933903
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy.
    Obeso JA; Grandas F; Vaamonde J; Luquin MR; Martinez-Lage JM
    Funct Neurol; 1988; 3(4):413-27. PubMed ID: 3072277
    [No Abstract]   [Full Text] [Related]  

  • 8. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
    Factor SA; Weiner WJ
    Mov Disord; 1993 Jul; 8(3):257-62. PubMed ID: 8341289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Parkinson's disease.
    Eadie MJ
    Aust Fam Physician; 1995 Sep; 24(9):1685-7, 1690-2. PubMed ID: 7487655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor response complications in advanced Parkinson's disease.
    Chase TN; Juncos JL; Fabbrini G; Mouradian MM
    Funct Neurol; 1988; 3(4):429-36. PubMed ID: 3072278
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of bromocriptine in the treatment of Parkinson's disease.
    Stern GM; Lees AJ; Shaw KM; Lander CM
    Adv Biochem Psychopharmacol; 1980; 23():267-70. PubMed ID: 7395617
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
    Hauser RA; Holford NH
    Mov Disord; 2002 Sep; 17(5):961-8. PubMed ID: 12360545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH; Ha JH; Cho IS; Lee MC
    J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of Parkinson's disease.
    Morris JG
    Med J Aust; 1985 Oct; 143(8):347-50. PubMed ID: 4046949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
    Pezzoli G; Martignoni E; Pacchetti C; Angeleri VA; Lamberti P; Muratorio A; Bonuccelli U; De Mari M; Foschi N; Cossutta E
    Mov Disord; 1994 Jul; 9(4):431-6. PubMed ID: 7969210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
    Hely MA; Morris JG; Reid WG; Trafficante R
    Mov Disord; 2005 Feb; 20(2):190-9. PubMed ID: 15551331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term use of dopamine agonists in Parkinson's disease.
    Jankovic J
    Clin Neuropharmacol; 1985; 8(2):131-40. PubMed ID: 3891082
    [No Abstract]   [Full Text] [Related]  

  • 19. Further experiences with low doses of bromocriptine in Parkinson's disease.
    Fahn S; Côté LJ; Barrett RE; Snider SR
    Adv Biochem Psychopharmacol; 1980; 23():255-60. PubMed ID: 7395615
    [No Abstract]   [Full Text] [Related]  

  • 20. Current controversies: levodopa in the treatment of Parkinson's disease.
    Sharma JC; Vassallo M; Ross IN
    Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.